[5]-Helistatins: Tubulin-Binding Helicenes with Antimitotic Activity
Rushworth, James L.; Thawani, Aditya R.; Fajardo-Ruiz, Elena; Meiring, Joyce C. M.; Heise, Constanze; White, Andrew J. P.; Akhmanova, Anna; Brandt, Jochen R.; Thorn-Seshold, Oliver; Fuchter, Matthew J.
(2022) JACS Au, volume 2, issue 11, pp. 2561 - 2570
(Article)
Abstract
Helicenes are high interest synthetic targets with unique conjugated helical structures that have found important technological applications. Despite this interest, helicenes have had limited impact in chemical biology. Herein, we disclose a first-in-class antimitotic helicene, helistatin 1 (HA-1), where the helicene scaffold acts as a structural mimic of colchicine, a
... read more
known antimitotic drug. The synthesis proceeds via sequential Pd-catalyzed coupling reactions and a π-Lewis acid cycloisomerization mediated by PtCl2. HA-1 was found to block microtubule polymerization in both cell-free and live cell assays. Not only does this demonstrate the feasibility of using helicenes as bioactive scaffolds against protein targets, but also suggests wider potential for the use of helicenes as isosteres of biaryls or cis-stilbenes─themselves common drug and natural product scaffolds. Overall, this study further supports future opportunities for helicenes for a range of chemical biological applications.
show less
Download/Full Text
Keywords: DNA, antiproliferative, cancer, cell cycle, helicene, mitosis, tubulin, Catalysis, General Chemistry, Biochemistry, Colloid and Surface Chemistry
ISSN: 2691-3704
Publisher: American Chemical Society
Note: Funding Information: Funding for this work was provided by the Commonwealth Scientific and Industrial Research Organization (CSIRO), Imperial College London, the EPSRC (EP/L014580/1, EP/R00188X/1), and the German Research Foundation (DFG: Emmy Noether grant no. 400324123 and SFB 1032 project B09 number 201269156 to O.T.S.). J.C.M.M. acknowledges support from an EMBO Long Term Fellowship (ALTF 261-2019). The authors also acknowledge the funding support from “Laboratory for Synthetic Chemistry and Chemical Biology” under the Health@InnoHK Program launched by Innovation and Technology Commission, The Government of Hong Kong Special Administrative Region of the People’s Republic of China. Publisher Copyright: © 2022 The Authors. Published by American Chemical Society.
(Peer reviewed)
See more statistics about this item